In vitro activity of telavancin against Staphylococcus aureus causing pneumonia or skin and skin structure infections with concomitant bloodstream infections in United States hospitals (2012-2016)

被引:0
|
作者
Duncan, Leonard R. [1 ]
Flamm, Robert K. [1 ]
Sader, Helio S. [1 ]
Mendes, Rodrigo E. [1 ]
机构
[1] JMI Labs, North Liberty, IA 52317 USA
关键词
Telavancin; Staphylococcus aureus; Bloodstream infection; SSSI; Pneumonia; BACTEREMIA; VANCOMYCIN; EPIDEMIOLOGY; MANAGEMENT; FOCUS;
D O I
10.1016/j.diagmicrobio.2018.09.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Pneumonia and skin and skin structure infections (SSSIs) caused by S. aureus can lead to serious bloodstream infections (BSIs). This study reports on potent telavancin in vitro activity (MIC90, 0.06 mu g/mL; 100% susceptible) against 674 US S. aureus causing pneumonia or SSSI with associated BSI in hospitalized patients during 2012-2016. (C) 2018 The Authors. Published by Elsevier Inc.
引用
收藏
页码:167 / 170
页数:4
相关论文
共 39 条
  • [1] Ceftobiprole Activity against Bacteria from Skin and Skin Structure Infections in the United States from 2016 through 2018
    Flamm, Robert K.
    Duncan, Leonard R.
    Hamed, Kamal A.
    Smart, Jennifer, I
    Mendes, Rodrigo E.
    Pfaller, Michael A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (06)
  • [2] Ceftaroline Activity Tested Against Bacterial Isolates Causing Community-acquired Respiratory Tract Infections and Skin and Skin Structure Infections in Pediatric Patients From United States Hospitals: 2012-2014
    Pfaller, Michael A.
    Mendes, Rodrigo E.
    Castanheira, Mariana
    Flamm, Robert K.
    Jones, Ronald N.
    Sader, Helio S.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (05) : 486 - 491
  • [3] Emerging Treatment Options for Acute Bacterial Skin and Skin Structure Infections and Bloodstream Infections Caused by Staphylococcus aureus: A Comprehensive Review of the Evidence
    Giacobbe, Daniele Roberto
    Dettori, Silvia
    Corcione, Silvia
    Vena, Antonio
    Sepulcri, Chiara
    Maraolo, Alberto Enrico
    De Rosa, Francesco Giuseppe
    Bassetti, Matteo
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 2137 - 2157
  • [4] In vitro activity of Tedizolid and comparators against isolates of methicillin-resistant Staphylococcus aureus causing skin and soft tissue infections in 7 hospitals in Colombia
    Lucia Leal, Aura
    Victoria Ovalle, Maria
    Alberto Cortes, Jorge
    Maria Montanes, Anita
    Rocio de la Rosa, Zandra
    Yesid Rodriguez, Jose
    Gualtero, Sandra
    Ariza, Beatriz
    Sussman, Otto
    del Pilar Torres, Maria
    BIOMEDICA, 2018, 38 (04):
  • [5] Activity of Tedizolid and Comparator Agents Against Gram-positive Isolates Causing Skin and Skin Structure Infections in Pediatric Patients in United States Hospitals (2015-2019)
    Carvalhaes, Cecilia Godoy
    Sader, Helio Silva
    Rhomberg, Paul Richard
    Castanheira, Mariana
    DeVries, Sean
    Mendes, Rodrigo Elisandro
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2022, 41 (09) : 731 - 735
  • [6] Ceftobiprole activity when tested against contemporary bacteria causing bloodstream infections in the United States (2016-2017)
    Pfaller, Michael A.
    Flamm, Robert K.
    Duncan, Leonard R.
    Shortridge, Dee
    Smart, Jennifer, I
    Hamed, Kamal A.
    Mendes, Rodrigo E.
    Sader, Helio S.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 94 (03) : 304 - 313
  • [7] Telavancin Activity against Gram-Positive Bacteria Isolated from Patients with Skin and Skin-Structure Infections
    Pfaller, M. A.
    Rhomberg, P. R.
    Sader, H. S.
    Mendes, R. E.
    Jones, R. N.
    JOURNAL OF CHEMOTHERAPY, 2010, 22 (05) : 304 - 311
  • [8] Telavancin activity tested against a collection of Staphylococcus aureus isolates causing pneumonia in hospitalized patients in the United States (2013-2014)
    Duncan, Leonard R.
    Smart, Jennifer I.
    Flamm, Robert K.
    Sader, Helio S.
    Jones, Ronald N.
    Mendes, Rodrigo E.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2016, 86 (03) : 300 - 302
  • [9] In vitro activity of telavancin against Gram-positive isolates from complicated skin and skin structure infections: results from 2 phase 3 (ATLAS) clinical studies
    Krause, Kevin M.
    Barriere, Steven L.
    Kitt, Michael M.
    Benton, Bret M.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2010, 68 (02) : 181 - 185
  • [10] Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical Centers
    Sader, Helio S.
    Farrell, David J.
    Flamm, Robert K.
    Jones, Ronald N.
    SURGICAL INFECTIONS, 2016, 17 (04) : 443 - 447